What this Trial Is About

Researchers are evaluating whether the Arthrex LoopLocTM device offers better capsular closure during primary hip arthroscopy compared to other treatments. The hip capsule is the tissue that surrounds and supports the hip joint, which must be cut during surgery. Traditional repair methods use knotted sutures that may irritate surrounding tissues, potentially causing scar tissue and pain. The LoopLocTM device is knotless and may reduce irritation and scarring, possibly improving patient outcomes. The study is a prospective, multi-center Phase 4 trial comparing two groups of patients undergoing primary hip arthroscopy for femoro acetabular impingement. One group will have their hip capsule closed using the LoopLocTM device, while the control group will have closure without this device. Patients will be followed for two years after surgery to collect clinical and patient-reported outcomes. Participants will be closely monitored through follow-up visits over two years. Researchers will collect data on hip function using tools like the Modified Harris Hip Score to assess outcomes. Patients will be informed about the study and provide consent before participation. The study will analyze whether the LoopLocTM device leads to better outcomes than other closure methods in hip arthroscopy.

Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study